These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 36434561)

  • 1. Are intersectoral costs considered in economic evaluations of interventions relating to sexually transmitted infections (STIs)? A systematic review.
    Schnitzler L; Evers SMAA; Jackson LJ; Paulus ATG; Roberts TE
    BMC Public Health; 2022 Nov; 22(1):2180. PubMed ID: 36434561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intersectoral costs of sexually transmitted infections (STIs) and HIV: a systematic review of cost-of-illness (COI) studies.
    Schnitzler L; Jackson LJ; Paulus ATG; Roberts TE; Evers SMAA
    BMC Health Serv Res; 2021 Oct; 21(1):1179. PubMed ID: 34715866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the costs and outcomes of control programmes for sexually transmitted infections: a systematic review of economic evaluations.
    Bloch SCM; Jackson LJ; Frew E; Ross JDC
    Sex Transm Infect; 2021 Aug; 97(5):334-344. PubMed ID: 33653881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CONCEPTUALIZATIONS OF THE SOCIETAL PERSPECTIVE WITHIN ECONOMIC EVALUATIONS: A SYSTEMATIC REVIEW.
    Drost RMWA; van der Putten IM; Ruwaard D; Evers SMAA; Paulus ATG
    Int J Technol Assess Health Care; 2017 Jan; 33(2):251-260. PubMed ID: 28641592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness and cost-effectiveness of behavioural interventions for the prevention of sexually transmitted infections in young people aged 13-19: a systematic review and economic evaluation.
    Shepherd J; Kavanagh J; Picot J; Cooper K; Harden A; Barnett-Page E; Jones J; Clegg A; Hartwell D; Frampton GK; Price A
    Health Technol Assess; 2010 Feb; 14(7):1-206, iii-iv. PubMed ID: 20178696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic Evaluation of Medically Assisted Reproduction: A Methodological Systematic Review.
    Van Muylder A; D'Hooghe T; Luyten J
    Med Decis Making; 2023; 43(7-8):973-991. PubMed ID: 37621143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement Instruments of Productivity Loss of Paid and Unpaid Work: A Systematic Review and Assessment of Suitability for Health Economic Evaluations From a Societal Perspective.
    Hubens K; Krol M; Coast J; Drummond MF; Brouwer WBF; Uyl-de Groot CA; Hakkaart-van Roijen L
    Value Health; 2021 Nov; 24(11):1686-1699. PubMed ID: 34711370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of antimicrobial resistance in curable sexually transmitted infections; a systematic review and a case study.
    Ayinde O; Ross JDC; Jackson L
    PLoS One; 2023; 18(10):e0292273. PubMed ID: 37856496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the inclusion of societal costs change the economic evaluations recommendations? A systematic review for multiple sclerosis disease.
    Rodríguez-Sánchez B; Daugbjerg S; Peña-Longobardo LM; Oliva-Moreno J; Aranda-Reneo I; Cicchetti A; López-Bastida J
    Eur J Health Econ; 2023 Mar; 24(2):247-277. PubMed ID: 35596098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intersectoral Costs and Benefits of Mental and Behavioural Disorders in the Education Sector: an Exploration of Costing Methods.
    Bremmers LGM; Evers SMAA; Drost RMWA; Janssen LMM; Pokhilenko I; Paulus ATG; Norton EC; Yoon J; Cuddeback GS; Morrissey JP
    J Ment Health Policy Econ; 2020 Sep; 23(3):115-137. PubMed ID: 33411675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How relevant are social costs in economic evaluations? The case of Alzheimer's disease.
    Peña-Longobardo LM; Rodríguez-Sánchez B; Oliva-Moreno J; Aranda-Reneo I; López-Bastida J
    Eur J Health Econ; 2019 Nov; 20(8):1207-1236. PubMed ID: 31342208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Including adverse drug events in economic evaluations of anti-tumour necrosis factor-α drugs for adult rheumatoid arthritis: a systematic review of economic decision analytic models.
    Heather EM; Payne K; Harrison M; Symmons DP
    Pharmacoeconomics; 2014 Feb; 32(2):109-34. PubMed ID: 24338344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are acceptance and mindfulness-based interventions 'value for money'? Evidence from a systematic literature review.
    Duarte R; Lloyd A; Kotas E; Andronis L; White R
    Br J Clin Psychol; 2019 Jun; 58(2):187-210. PubMed ID: 30499217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are We Capturing the Socioeconomic Burden of Rare Genetic Disease? A Scoping Review of Economic Evaluations and Cost-of-Illness Studies.
    Marshall DA; Gerber B; Lorenzetti DL; MacDonald KV; Bohach RJ; Currie GR
    Pharmacoeconomics; 2023 Dec; 41(12):1563-1588. PubMed ID: 37594668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs and economic evaluations of Quality Improvement Collaboratives in healthcare: a systematic review.
    de la Perrelle L; Radisic G; Cations M; Kaambwa B; Barbery G; Laver K
    BMC Health Serv Res; 2020 Mar; 20(1):155. PubMed ID: 32122378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methodological issues in economic evaluations of disease prevention and health promotion: an overview of systematic and scoping reviews.
    Seleznova Y; Alayli A; Stock S; Müller D
    BMC Public Health; 2021 Nov; 21(1):2130. PubMed ID: 34801013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the Effect of Including Social Costs in Economic Evaluations of Diabetes-Related Interventions: A Systematic Review.
    Rodriguez-Sanchez B; Aranda-Reneo I; Oliva-Moreno J; Lopez-Bastida J
    Clinicoecon Outcomes Res; 2021; 13():307-334. PubMed ID: 33953579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems.
    Main C; Moxham T; Wyatt JC; Kay J; Anderson R; Stein K
    Health Technol Assess; 2010 Oct; 14(48):1-227. PubMed ID: 21034668
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.